Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutant RAS and the tumor microenvironment as dual therapeutic targets for advanced colorectal cancer
Jorien B.E. Janssen, Jan Paul Medema, Elske C. Gootjes, et al.
Cancer Treatment Reviews (2022) Vol. 109, pp. 102433-102433
Open Access | Times Cited: 24

Showing 24 citing articles:

Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 90
Nanomaterials: Breaking through the bottleneck of tumor immunotherapy
Yue Kang, Shenglong Li
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123159-123159
Closed Access | Times Cited: 33
Anti‐angiogenesis in colorectal cancer therapy
Zhenni Yang, Xuqian Zhang, Xiaozhe Bai, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 734-751
Open Access | Times Cited: 12
Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies
Wei‐Fang Zuo, Qiwen Pang, Xinyu Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Targeting the “tumor microenvironment”: RNA-binding proteins in the spotlight in colorectal cancer therapy
Yiwei Zhang, Yujun Zhang, Jingjing Song, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111876-111876
Closed Access | Times Cited: 6
Systemic therapies for localized colon cancer and metastatic colorectal cancer
James R. Platt
Elsevier eBooks (2025), pp. 37-51
Closed Access
M1 macrophage-derived exosome for reprograming M2 macrophages and combining endogenous NO gas therapy with enhanced photodynamic synergistic therapy in colorectal cancer
Ruo‐Yun Zhang, Kai Cheng, Zhuoyao Huang, et al.
Journal of Colloid and Interface Science (2023) Vol. 654, pp. 612-625
Closed Access | Times Cited: 11
Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer
Ece Ozmen, Tevriz Dilan Demir, Gülnihal Özcan
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 3
Genetic alterations shape innate immune cells to foster immunosuppression and cancer immunotherapy resistance
Louis Boafo Kwantwi
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4289-4296
Closed Access | Times Cited: 7
SOS1-inspired hydrocarbon-stapled peptide as a pan-Ras inhibitor
Anpeng Li, Xiang Li, Jihua Zou, et al.
Bioorganic Chemistry (2023) Vol. 135, pp. 106500-106500
Closed Access | Times Cited: 6
TMSB4X: A novel prognostic marker for non-small cell lung cancer
Ze Yang, Jihang Luo, Mengmei Zhang, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21505-e21505
Open Access | Times Cited: 6
Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review
Shixun Ma, Li Li, Hui Cai, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 2, pp. 81-88
Open Access | Times Cited: 5
Patient‐derived xenograft model in colorectal cancer basic and translational research
Xiaofeng Liu, Zechang Xin, Kun Wang
Animal Models and Experimental Medicine (2022) Vol. 6, Iss. 1, pp. 26-40
Open Access | Times Cited: 8
New insights into RAS in head and neck cancer
Sankar Jagadeeshan, Ofra Novoplansky, Oded Cohen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188963-188963
Closed Access | Times Cited: 4
Impact of Molecular Status on Cytoreductive Surgery for Peritoneal Metastases from Colorectal Cancer
Yun Zhong, Keli Yang, Xiusen Qin, et al.
Clinics in Colon and Rectal Surgery (2023) Vol. 36, Iss. 06, pp. 415-422
Open Access | Times Cited: 2
SIM2: Its Prognostic Significance and Oncogenic Role in Endometrial Carcinoma
Yunfang Wei, Xianlei Zhao, Hong Tang, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 45-61
Open Access
High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoids
Kirti K. Iyer, Dennis Poel, Anne Miggelenbrink, et al.
BJC Reports (2024) Vol. 2, Iss. 1
Open Access
WWP1 inhibition increases SHP2 inhibitor efficacy in colorectal cancer
Hao Fan, Xuefei Hu, Fuao Cao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
Effect of colorectal cancer stem cells on the development and metastasis of colorectal cancer
Runzhi Deng, X. W. Zheng, Zhonglei Lu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 11, pp. 4354-4368
Closed Access
Updated Survival Outcome of Regorafenib, Ipilimumab, and Nivolumab in Refractory Microsatellite Stable Non-Liver Metastatic Colorectal Cancer: A Phase I Nonrandomized Clinical Trial
Annie Xiao, Xiaochen Li, Chongkai Wang, et al.
European Journal of Cancer (2024) Vol. 213, pp. 115111-115111
Closed Access
KRAS inhibitors in drug resistance and potential for combination therapy
Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale
Tumori Journal (2024)
Closed Access
NETosis Genes and Pathomic Signature: A Novel Prognostic Marker for Ovarian Serous Cystadenocarcinoma
Feng Zhan, Yina Guo, Lidan He
Deleted Journal (2024)
Closed Access
A PDX model combined with CD-DST assay to evaluate the antitumor properties of KRpep-2d and oxaliplatin in KRAS (G12D) mutant colorectal cancer
Wuguo Li, Wei Chen, Jialin Wang, et al.
Heliyon (2022) Vol. 8, Iss. 12, pp. e12518-e12518
Open Access | Times Cited: 2
Quantification of VT204 in rat plasma by LC-MS/MS and its pharmacokinetic study
Xuechao Yang, Shu Zhang, Xiaochuan Li, et al.
International Journal of Frontiers in Medicine (2023) Vol. 5, Iss. 11
Open Access
Page 1

Scroll to top